v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 206,535 $ 20,291
Marketable securities 187,720 115,194
Prepaid expenses and other current assets 9,547 2,588
Total current assets 403,802 138,073
Non-current marketable securities 21,932 0
Property and equipment, net 465 701
Right-of-use assets 5,260 169
Other assets 3,227 2,909
Total assets 434,686 141,852
Current liabilities:    
Accounts payable 3,828 1,096
Accrued research and development expenses 5,633 6,530
Development financing liability - current portion 10,000 0
Deferred collaboration revenue - current portion 1,689 0
Other accrued liabilities 15,693 7,815
Total current liabilities 36,843 15,441
Development financing liability - non-current portion 99,172 90,227
Deferred collaboration revenue - non-current portion 1,100 0
Lease liabilities - non-current portion 5,315 30
Total liabilities 142,430 105,698
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value: 200,000,000 shares authorized; 113,864,976 and 84,681,063 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively 11 8
Additional paid-in capital 1,270,328 909,329
Accumulated other comprehensive income (loss) 144 (326)
Accumulated deficit (978,227) (872,857)
Total stockholders' equity 292,256 36,154
Total liabilities and stockholders' equity $ 434,686 $ 141,852

Source

HTML PDF
ZIP